haleon.com (HLN) - Company Sales Revenue

Corporate emblem and logo of Haleon (HLN)

Haleon plc generates revenue through the sale of well-known hygiene and over-the-counter medicine brands while maintaining excess liquidity to reduce debt. The company's sales trajectory reflects sales activity dynamics, with the current figure standing at 14.97. This non-cyclical asset demonstrates high resilience to macroeconomic shocks, featuring a pronounced seasonal surge in demand during the winter period.

Haleon Corp (HLN): Company Revenue from 04/28/2023 to 11/17/2026

Analytical breakdowns for Haleon plc

- market capitalization indicators:
Comprehensive company analysis:Haleon HLN
Original product of Haleon plc

This indicator serves as the basis for fundamental valuation, reflecting the intensity of incoming cash flows. It captures daily sales volume, enabling the identification of short-term price extremes. By analyzing changes in sales, an investor assesses asset liquidity and avoids value traps. For Haleon plc (HLN), this metric confirms stable demand for pharmacy brands. High product recognition ensures revenue stability for this healthcare behemoth.

Competing companies

Company Total Revenue kenvue.com KVUE|Company Revenue Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Company Sales Revenue|Company Revenue Ligand Pharma LGND|Revenue and Sales Volume Amneal Corp AMRX|Perrigo Company PLC - Revenue and Sales Volume|ALVO: Company Revenue|liquidia.com (LQDA) - Company Revenue|GLPG (Galapagos) - Company Revenue|Company Sales ANIP|Company Sales Volume MNKD (Afrezza)|Revenue and Sales Volume AMPH|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP